Cardiac Toxicity Completed Phase 3 Trials for Enalapril (DB00584)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003070Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood CancerSupportive Care